Atjaunināt sīkdatņu piekrišanu

Sanford Guide to Antimicrobial Therapy 40th 2010 ed. [Spiral bound]

4.40/5 (365 ratings by Goodreads)
Edited by , Edited by , Edited by , Edited by , Edited by
  • Formāts: Spiral bound, 220 pages, height x width x depth: 215x121x18 mm, weight: 281 g, Tables, black and white
  • Sērija : Sanford Guides
  • Izdošanas datums: 01-Apr-2010
  • Izdevniecība: Antimicrobial Therapy
  • ISBN-10: 1930808607
  • ISBN-13: 9781930808607
Citas grāmatas par šo tēmu:
  • Spiral bound
  • Cena: 41,08 €*
  • * Šī grāmata vairs netiek publicēta. Jums tiks paziņota lietotas grāmatas cena
  • Šī grāmata vairs netiek publicēta. Jums tiks paziņota lietotas grāmatas cena.
  • Daudzums:
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
Sanford Guide to Antimicrobial Therapy 40th 2010 ed.Palielināt
  • Formāts: Spiral bound, 220 pages, height x width x depth: 215x121x18 mm, weight: 281 g, Tables, black and white
  • Sērija : Sanford Guides
  • Izdošanas datums: 01-Apr-2010
  • Izdevniecība: Antimicrobial Therapy
  • ISBN-10: 1930808607
  • ISBN-13: 9781930808607
Citas grāmatas par šo tēmu:
Permanent link: https://www.kriso.lv/db/9781930808607.html
Abbreviations 2(2)
Table 1
Table 1A Clinical Approach To Initial Choice Of Antimicrobial Therapy
4(58)
Table 2 Recommended Antimicrobial Agents Against Selected Bacteria 62(3)
Table 3 Suggested Duration Of Antibiotic Therapy In Immunocompent Patients 65(1)
Table 4 Comparison Of Antibacterial Spectra 66(6)
Table 5 Treatment Options For Selected Highly Resistant Bacteria 72(2)
Table 6 Suggested Management Of Suspected Or Culture-Positive Community-Associated Methicillin-Resistant S. Aureus (Ca-Mrsa) Infections 74(2)
Table 7 Methods For Drug Desensitization 76(1)
Table 8 Risk Categories Of Antimicrobics In Pregnancy 77(1)
Table 9
9A Selected Pharmacologic Features Of Antimicrobial Agents
78(5)
9B Pharmacodynamics Of Antibacterials
83(1)
Table 10
10A Selected Antibacterial Agents—adverse Reactions—overview
84(4)
10B Antimicrobial Agents Associated With Photosensitivity
88(1)
10C Antibiotic Dosage And Side-Effects
89(8)
10D Aminoglycoside Once-Daily And Multiple Daily Dosing Regimens
97(1)
Table 11
11A Treatment Of Fungal Infections—antimicrobial Agents Of Choice
98(14)
11B Antifungal Drugs: Dosage, Adverse Effects, Comments
112(3)
11C At A Glance Summary Of Suggested Antifungal Drugs Against Treatable Pathogenic Fungi
115(1)
Table 12
12A Treatment Of Mycobacterial Infections
116(10)
12B Dosage And Adverse Effects Of Antimycobacterial Drugs
126(3)
Table 13
13A Treatment Of Parasitic Infections
129(10)
13B Dosage And Selected Adverse Effects Of Antiparasitic Drugs
139(3)
13C Parasites That Cause Eosinophilia (Eosinophilia In Travelers)
142(1)
Table 14
14A Antiviral Therapy (Non-Hiv)
143(12)
14B Antiviral Drugs (Non-Hiv)
155(5)
14C At A Glance Summary Of Suggested Antiviral Agents Against Treatable Pathogenic Viruses
160(1)
14D Antiretroviral Therapy In Treatment-Naive Adults (Hiv/aids)
161(10)
14E Antiretroviral Drugs And Adverse Effects (Hiv/aids)
171(3)
Table 15
15A Antimicrobial Prophylaxis For Selected Bacterial Infections
174(1)
15B Surgical Antibiotic Prophylaxis
175(4)
15C Antimicrobial Prophylaxis For The Prevention Of Bacterial Endocarditis In Patients With Underlying Cardiac Conditions
179(1)
15D Management Of Exposure To Hiv-1 And Hepatitis B And C
180(3)
15E Prevention Of Opportunistic Infection In Human Stem Cell Transplantation (Hsct) Or Solid Organ Transplantation (Sot) For Adults With Normal Renal Function
183(2)
Table 16 Pediatric Dosages Of Selected Antibacterial Agents 185(1)
Table 17
17A Dosages Of Antimicrobial Drugs In Adult Patients With Renal Impairment
186(8)
17B No Dosage Adjustment With Renal Insufficiency By Category
194(1)
Table 18 Antimicrobials And Hepatic Disease: Dosage Adjustment 194(1)
Table 19 Treatment Of Capd Peritonitis In Adults 194(1)
Table 20
20A Recommended Childhood And Adolescent Immunization Schedule In The United States
195(1)
20B Adult Immunization In The United States
196(2)
20C Anti-Tetanus Prophylaxis, Wound Classification, Immunization
198(1)
20D Rabies Post-Exposure Prophylaxis
199(1)
Table 21 Selected Directory Of Resources 200(1)
Table 22
22A Anti-Infective Drug-Drug Interactions
201(7)
22B Drug-Drug Interactions Between Non-Nucleoside Reverse Transcriptase Inhibitors (Nnrtis) And Protease Inhibitors
208(1)
Table 23 List Of Generic And Common Trade Names 209(2)
Index Of Major Entities 211